A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation
Mallika Lala, Tommy Li, Dinesh P. de Alwis, Vikram Sinha, Kapil Mayawala, Noboru Yamamoto, Lillian L. Siu, Elliot Chartash, Hesham Aboshady, Lokesh Jain
Topics & Concepts
DosingPembrolizumabScheduleMedicineCancerOncologyMedical physicsIntensive care medicineComputer scienceInternal medicineImmunotherapyOperating systemCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesPsoriasis: Treatment and Pathogenesis